Networking the host immune response in Plasmodium vivax malaria

Area of Science:

• Immunology
• Infectious Diseases
• Network Medicine

Background:

• Host factors significantly influence Plasmodium vivax malaria clinical outcomes.
• Determinants of severe P. vivax malaria susceptibility remain largely unknown.
• Network analysis can identify biomarker-clinical outcome associations.

Purpose of the Study:

• To investigate host molecular and genetic factors associated with P. vivax malaria severity.
• To identify patterns between biomarkers and clinical outcomes using network analysis.
• To understand the immunological basis of P. vivax malaria severity.

Main Methods:

• Retrospective analysis of 530 individuals from the Brazilian Amazon.
• Included asymptomatic, symptomatic, severe non-lethal, severe lethal P. vivax malaria, and non-infected controls.
• Measured plasma biomarkers (liver enzymes, bilirubin, creatinine, fibrinogen, CRP, SOD-1, HO-1, cytokines, chemokines) and performed network analysis.

Main Results:

• Non-infected controls showed interactions between IL-10, IL-4, and CXCL9.
• Asymptomatic malaria involved significant interactions with IL-4.
• Mild/severe non-lethal malaria showed reduced network interactions, with TNF frequently associated.
• Lethal malaria cases linked to interactions between TNF, ALT, HO-1, and SOD-1.

Conclusions:

• Clinical immunity to P. vivax malaria is associated with complex network interactions, particularly involving IL-4.
• Lethality in P. vivax malaria correlates with reduced network complexity.
• Increased connections between haemolysis markers are linked to lethal P. vivax malaria outcomes.